Trial · NCT03660839
Results by group278
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 278
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) at Day 28 (ACPR28) | Ferroquine 400 mg | 80.8 | 95% Confidence Interval 62.1 to 91.5 | percentage of participants | |
| Percentage of Participants With Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) at Day 28 (ACPR28) | Ferroquine 400 mg + Artefenomel 300 mg | 90.3 | 95% Confidence Interval 75.1 to 96.7 | percentage of participants | |
| Percentage of Participants With Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) at Day 28 (ACPR28) | Ferroquine 400 mg + Artefenomel 600 mg | 90.9 | 95% Confidence Interval 76.4 to 96.9 | percentage of participants | |
| Percentage of Participants With Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) at Day 28 (ACPR28) | Ferroquine 400 mg + Artefenomel 1000 mg | 87.1 | 95% Confidence Interval 71.1 to 94.9 | percentage of participants | |
| Percentage of Participants With Crude Adequate Clinical and Parasitological Response at Day 28 | Ferroquine 400 mg | 64.5 | 95% Confidence Interval 46.9 to 78.9 | percentage of participants | |
| Percentage of Participants With Crude Adequate Clinical and Parasitological Response at Day 28 | Ferroquine 400 mg + Artefenomel 300 mg | 81.8 | 95% Confidence Interval 65.6 to 91.4 | percentage of participants | |
| Percentage of Participants With Crude Adequate Clinical and Parasitological Response at Day 28 | Ferroquine 400 mg + Artefenomel 600 mg | 77.8 | 95% Confidence Interval 61.9 to 88.3 | percentage of participants | |
| Percentage of Participants With Crude Adequate Clinical and Parasitological Response at Day 28 | Ferroquine 400 mg + Artefenomel 1000 mg | 78.1 | 95% Confidence Interval 61.2 to 89 | percentage of participants | |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg | Baseline | 17496.0 | Standard Deviation 11889.55 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 300 mg | Baseline | 18799.6 | Standard Deviation 13559.14 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 600 mg | Baseline | 15171.9 | Standard Deviation 13012.53 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 1000 mg | Baseline | 20546.8 | Standard Deviation 13835.31 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg | Change from baseline at 6 hours post-dose | -1349.3 | Standard Deviation 11331.78 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 300 mg | Change from baseline at 6 hours post-dose | -96.9 | Standard Deviation 11699.28 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 600 mg | Change from baseline at 6 hours post-dose | 8515.4 | Standard Deviation 44264.14 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 1000 mg | Change from baseline at 6 hours post-dose | 893.2 | Standard Deviation 21052.27 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg | Change from baseline at 12 hours post-dose | -5721.5 | Standard Deviation 12441.39 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 300 mg | Change from baseline at 12 hours post-dose | -11471.6 | Standard Deviation 13399.27 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 600 mg | Change from baseline at 12 hours post-dose | -4156.6 | Standard Deviation 34663.71 | parasites per microliter |
| Parasitemia: Change From Baseline in Number of Parasites Per Microliter of Blood at 6, 12, 18, 24, 30, 36, 48, 72, 96, 120, 144 and 168 Hours | Ferroquine 400 mg + Artefenomel 1000 mg | Change from baseline at 12 hours post-dose | -11319.4 | Standard Deviation 15490.43 | parasites per microliter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03660839/results